Back to Search Start Over

Susceptibility Profile ofStaphylococcus epidermidisandStaphylococcus haemolyticusIsolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years

Authors :
Adilson de Oliveira
Maria de Lourdes Ribeiro de Souza da Cunha
Valéria Cataneli Pereira
Carla Ivo Brito
Carlos Henrique Camargo
Ariane R. Bartolomeu
Luiza Pinheiro
Universidade Estadual Paulista (Unesp)
São Paulo
Source :
Scopus, Repositório Institucional da UNESP, Universidade Estadual Paulista (UNESP), instacron:UNESP
Publication Year :
2016
Publisher :
Mary Ann Liebert Inc, 2016.

Abstract

Made available in DSpace on 2018-12-11T17:03:21Z (GMT). No. of bitstreams: 0 Previous issue date: 2016-06-01 The aim of this study was to evaluate the antimicrobial susceptibility profile of 85 Staphylococcus epidermidis and 84 Staphylococcus haemolyticus strains isolated from blood cultures to oxacillin, vancomycin, tigecycline, linezolid, daptomycin, and quinupristin/dalfopristin over a period of 12 years. S. epidermidis and S. haemolyticus isolated from blood cultures of inpatients, attended at a teaching hospital, were analyzed for the presence of the mecA gene and by SCCmec typing. The minimum inhibitory concentration (MIC) values of tigecycline, linezolid, daptomycin, quinupristin/dalfopristin, and vancomycin were determined. Isolates exhibiting vancomycin MICs of ≥2 μg/ml were typed by pulsed-field gel electrophoresis (PFGE). The rate of mecA positivity was 92.9% and 100% in S. epidermidis and S. haemolyticus, respectively. The most frequent SCCmec types were type III (53.2%) in S. epidermidis and type I (32.1%) in S. haemolyticus. All isolates were susceptible to linezolid and daptomycin, but 7.1% of S. haemolyticus and 2.3% of S. epidermidis isolates were resistant to tigecycline, and 1.2% each of S. haemolyticus and S. epidermidis were resistant and intermediately resistant to quinupristin/dalfopristin, respectively. S. epidermidis exhibited higher vancomycin MICs (40% with MIC of ≥2 μg/ml). Clonal typing of strains with vancomycin MIC of ≥2 μg/ml revealed the presence of different PFGE types of S. epidermidis and S. haemolyticus over a period of up to 4 years (2002-2004, 2005-2008, 2006-2009, 2010-2011). Despite the observation of a high prevalence of mecA, the clinical strains were fully susceptible to vancomycin and to the new drugs linezolid, daptomycin, tigecycline, and quinupristin/dalfopristin. The PFGE types with vancomycin MIC of ≥2 μg/ml exhibited a great diversity of SCCmec cassettes, demonstrating that S. epidermidis and S. haemolyticus may easily acquire these resistance-conferring genetic elements. Departamento de Microbiologia e Imunologia Instituto de Biociências Universidade Estadual Paulista (UNESP), Distrito de Rubião Jr. s/n Nucleo de Doencas Entericas e Infeccoes Por Patogenos Especiais Centro de Bacteriologia Instituto Adolfo Lutz São Paulo Departamento de Microbiologia e Imunologia Instituto de Biociências Universidade Estadual Paulista (UNESP), Distrito de Rubião Jr. s/n

Details

ISSN :
19318448 and 10766294
Volume :
22
Database :
OpenAIRE
Journal :
Microbial Drug Resistance
Accession number :
edsair.doi.dedup.....6829878353b16f85415763305b5162f2
Full Text :
https://doi.org/10.1089/mdr.2015.0064